Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
89,995,146
-
Share change
-
+5,243,755
-
Total reported value
-
$1,058,985,515
-
Put/Call ratio
-
86%
-
Price per share
-
$11.77
-
Number of holders
-
123
-
Value change
-
+$56,996,873
-
Number of buys
-
75
-
Number of sells
-
31
Institutional Holders of ALDER BIOPHARMACEUTICALS INC - COM (ALDR) as of Q2 2019
As of 30 Jun 2019,
ALDER BIOPHARMACEUTICALS INC - COM (ALDR) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,995,146 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., VANGUARD GROUP INC, Bellevue Group AG, GOLDMAN SACHS GROUP INC, SAMLYN CAPITAL, LLC, STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
123
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.